The number of patients who flock to India to get treatment continues to rise even after a report published in a leading British medical journal warned of patients who travel to the country getting infected with a possible "superbug".
Last week's report in The Lancet has got its fair share of criticism from a number of leading medical experts in India who claim that such an infection is being found in patients who have never travelled to the country. There were fears that the report would drastically affect the booming "medical tourism" to the country but a number of foreigners continue to come to India to get the treatment which is either not available or too expensive in their own country.
Canadian Sandra Kniffen was told by doctors in her country that they could do nothing more to ease her problems due to multiple sclerosis. However the 57-year old travelled to India following an advice from her friend and is now looking forward to visiting Taj Mahal after a successful surgery.
"People at home said I should wait, but I'm going to be 90 before this is available in Canada. It's not like we don't have problems in Canada, too. We have had SARS and the H1N1 flu and I can honestly say this has been first-class treatment", she said.